Indications and uses
helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
apply liberally 15 minutes before sun exposure use a water resistant sunscreen if swimming or sweating reapply at least every 2 hours children under 6 months of age: Ask a doctor Sun Protection Measures . Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures...
Avobenzone 2.8% .................Sunscreen
Homosalate 9.5% .....................Sunscreen
Octisalate 4.8% ..................Sunscreen
Octocrylene 7% .................Sunscreen
Sunscreen
For external use only
on damaged or broken skin
keep out of eyes. Rinse with water to remove.
rash occurs.
If swallowed, get medical help or contact a Poison Control Center right away.
Water, Glycerin, Dipropylene Glycol, Panthenol (Vitamin B5), Ethylhexyl Methoxycrylene, lsopropyl Palmitate, Silica, Niacinamide, Cetearyl Olivate, Cetearyl Alcohol, Glyceryl Stearate, Potassium Cetyl Phosphate, Sorbitan Olivate, Tocopheryl Acetate (Vitamin E Acetate), Caprylyl Glycol, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Palmitic Acid, Ethylhexylglycerin, Stearic Acid, Leontopodium Alpinum Flower/Leaf Extract, 1,2-Hexanediol, Oryza Saliva (Rice) Lees Extract, Propanediol, Sodium Hydroxide, Adenosine, Citric Acid, Myristic Acid, Tocopherol (Vitamin E), Buddleja Davidii (Summer Lilac) Leaf Extract, Thymus Vulgaris (Thyme) Leaf Extract
1-866-735-4137

NEW
DERMATOLOGIST RECOMMENDED
FOR SENSITIVE SKIN
Cetaphil®
SUN
35
Hydrating Face
Sunscreen
Broad Spectrum SPF 35
Formulated for sensitive skin
Oil-free, lightweight
sunscreen hydrates and
protects against
sun damage
Antioxidant Vitamins B3 and E
plus Vitamin B5
Skin Cancer Foundation logo
3 FL OZ (88 mL)
Distributed by:
Galderma Laboratories, L.P.
Dallas, Texas 75201 USA
All trademarks are the property of their respective owners.
cetaphil.com
P57554-0
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d676a241-be05-4740-b3ee-1a5f2ed422d2 | Product name | 4 | 20180615 |
| dd8bd48f-20d6-43c7-b471-3ae872868afa | Product name | 3 | 20180125 |
| d41954ff-bc63-4b2c-aba0-9146707659d7 | Product name | 2 | 20151117 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0299-4142-00 | Cetaphil Hydrating Face Sunscreen SPF 35 | 1 in 1 CARTON | LOTION | 1 | 1 | |
| 0299-4142-00 | Cetaphil Hydrating Face Sunscreen SPF 35 | 88 mL in 1 BOTTLE, PUMP | LOTION | 88 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0299-4142 | CETAPHIL HYDRATING FACE SUNSCREEN SPF 35 (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) LOTION [GALDERMA LABORATORIES, L.P.] | 1 | Current NDC, 2 package rows | 20231101_e924bfd5-d64d-4918-b57b-7d4da28bd013.zip |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0299-4142 | 0299-4142-00 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cetaphil Hydrating Face Sunscreen SPF 35 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | Galderma Laboratories, L.P. | e924bfd5-d64d-4918-b57b-7d4da28bd013 | 2023-10-24 | Warnings | 0299-4142-00 0299-4142 00299414200 6eb7c1fe-9c87-4330-a245-e20a0f66aa56 e924bfd5-d64d-4918-b57b-7d4da28bd013 |
Adverse event summaries are temporarily unavailable. Other product information remains available.